ICU Medical Announces Q3 2026 Results and Reaffirms Fiscal 2026 Guidance
ICU Medical reported Q3 2026 GAAP revenue of $560.4 million and reaffirmed its fiscal year 2026 guidance range for net income ($73-$83 million) and diluted EPS ($2.89-$3.29).
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed